"Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment"
There are currently four approved SGLT-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin) that have been approved by the FDA for their use in adults
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Researchers often find themselves weighing the distinct advantages of each, prompting the critical question: what truly differentiates 5-Amino-1MQ vs AOD-9604
Bruce Ames (bitte googeln) * zum Schutz des Hirngewebes vor Alterung durch freie Radikale und Ablagerungen fehlerhafter Proteine (Lipofuscin) * zum Erhalt eines gesunden Cardiolipinspiegels im Hirngewebe bei zunehmendem Altern
Petersen M, Chorzalska A, Pardo M, Rodriguez A, Morgan J, Ahsan N, Zhao TC, Liang O, Kotula L, Bertone P et al